Winter Offer

EquityTips

EquityTips
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

free stock cash Tips

Sunday, July 30, 2017

Equity Tips

Sensex @ 32K but here are top 20 laggards of 2017; here’s what to do if you own them

Indian market is up over 22 percent and scaled the fresh peak in the year 2017 but not every stock became a multibagger or outperformed the benchmark index. The S&P BSE Sensex rose over 32K while Nifty50 rallied over 10,000 mark for the first time last week.

In the Nifty 500 index, almost 70 stocks gave negative returns of up to 80 percent so far in the year 2017.

Among the laggards of 2017, Shilpi Cable slipped over 80 percent followed by Videocon Industries which was down 76 percent, and Nitin Fire plunged 74 percent as of data collated on 25 July 2017.

Other stocks which have taken a beating include names like Religare Enterprises, Inox Wind, Lupin, Divi’s Laboratories, Indoco Remedies, Dr. Lal Pathlabs, Ajanta Pharma, Glenmark Pharma among others.

On the other hand, top stocks which have made money for investors include names like JP Associates, Avanti Feeds, Future Retail, Indiabulls Real Estate, Rain Industries, Adani Transmission, Dilip Buildcon, Unitech, Sterlite Technologies, Escorts etc. among others.

Most of the pharma and IT stocks featured in the top 20 list of stocks which gave negative returns so far in the year 2017 largely on account of domestic as well as global headwinds.

“Investors should stay invested only in Companies with good management and with attractive business models. It is better to avoid buying the stock which is largely corrected if the quality of management is not good or promoters have heavily pledged their shares,”

“Most of the stocks in the list are either from pharma or energy (or energy related) sector. Both the sectors have underperformed due to sector specific issues and we have been negative on them for almost a year now,” Gaurav Dua, Head of Research, Sharekhan told Monecontrol.

“However, these stocks have a correction (both price and time wise) and one can start looking selectively at pharma space whereas we see value in the gas value chain in the oil& gas sector,”

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
Categories:

0 comments:

Post a Comment